Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertension in Young Adults Trial
NCT05370599Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Apr 2022
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amlodipine, chlorthalidone, losartan in hypertension (HTN), sponsored by University of California, San Francisco. Started Apr 2022; status: terminated.
02
Drugs
amlodipinechlorthalidonelosartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05370599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05370599.